Medifast
MED
#9033
Rank
NZ$0.22 B
Marketcap
NZ$20.48
Share price
0.81%
Change (1 day)
-27.47%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2025 (TTM): -NZ$9.76 Million

According to Medifast's latest financial reports the company's current earnings are NZ$0.42 Billion. In 2024 the company made an earning of NZ$5 Million a decrease over its 2023 earnings that were of NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$9.76 Million-295.1%
2024 NZ$5 M-97.72%
2023 NZ$0.21 B-31.61%
2022 NZ$0.32 B-14.56%
2021 NZ$0.37 B61.25%
2020 NZ$0.23 B47.36%
2019 NZ$0.15 B31.82%
2018 NZ$0.11 B74.26%
2017 NZ$68.86 M47.56%
2016 NZ$46.66 M-6.36%
2015 NZ$49.83 M-16.28%
2014 NZ$59.52 M2%
2013 NZ$58.36 M44.4%
2012 NZ$40.41 M-16.75%
2011 NZ$48.55 M-12.14%
2010 NZ$55.25 M63.85%
2009 NZ$33.72 M136.71%
2008 NZ$14.24 M35.74%
2007 NZ$10.49 M-142.56%
2006 -NZ$24.67 Million-448.43%
2005 NZ$7.07 M35.62%
2004 NZ$5.21 M-16.51%
2003 NZ$6.25 M
2000 NZ$0.84 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 2,697.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-NZ$19.18 Million 93.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
NZ$0.14 B-1,550.26%๐Ÿ‡บ๐Ÿ‡ธ USA